Twin Tree Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
VPM
VCM
Twin Tree Management's IONS Position: Q1 2026 in Review
Twin Tree Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 32,476 shares — an estimated $2.57M sold.
Twin Tree Management first reported a position in IONS in Q2 2015 and held it in 18 quarters. The position peaked at $3.11M in Q4 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Twin Tree Management reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Twin Tree Management sold 32,476 Ionis Pharmaceuticals shares in Q1 2026, an estimated $2.57M.
- Twin Tree Management first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 18 quarters.
- Twin Tree Management's Ionis Pharmaceuticals position peaked at $3.11M in Q4 2024.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.